Stack analysis
Saw palmetto + nettle root + pygeum
LUTS / prostate symptom retail stacks (benign prostate hype).
Confidence
62/100
Registry ingredients
Structured entries from our supplement intelligence registry (not personalized recommendations).
- Saw palmetto (Serenoa repens)herb
Evidence tier: medium·Typical label range: Liposterolic extracts often 320 mg/day in trials.
- Stinging nettle root (Urtica dioica)herb
Evidence tier: medium·Typical label range: Root extracts for LUTS vs leaf for allergies - different products.
- Pygeum (Prunus africana bark)herb
Evidence tier: low·Typical label range: Extract doses vary; sustainability concerns.
What this stack claims
Better urinary flow, fewer night wakings, ‘prostate support’ - claims often exceed consistent trial effect sizes.
Biological logic
Multiple botanicals are used in European traditions; mechanisms are not as clean as alpha-blocker pharmacology.
Evidence level
Registry tier for this stack: MEDIUM
Saw palmetto evidence is mixed (large US trial negative). Nettle/pygeum add complexity without a unified dose standard. Not a cancer strategy.
Risks
Bleeding surgery timing concerns with some herbals; PSA interpretation; delayed diagnosis of serious urologic conditions if symptoms worsen quietly.
Final verdict
**Optional adjunct tier** for some mild LUTS conversations with urology; **not a replacement** for evaluation when symptoms are moderate/severe.
FAQ
- Does it shrink the prostate?
- Do not expect medication-class effects; outcomes vary and may be modest or placebo-like depending on trial.
- Can it affect PSA tests?
- Discuss with urology - any supplement that alters symptoms or inflammation could confuse monitoring contexts.
- Pygeum sustainability?
- Sourcing concerns exist; quality and ethics vary by supplier.